(VIANEWS) – SELVAAG BOLIG (SBO.OL), BW LPG (BWLPG.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SELVAAG BOLIG (SBO.OL)
31.3% sales growth and 8.14% return on equity
Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.
Earnings Per Share
As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr1.94.
PE Ratio
SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 17.27. Meaning, the purchaser of the share is investing kr17.27 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.14%.
Volume
Today’s last reported volume for SELVAAG BOLIG is 9834 which is 82.48% below its average volume of 56133.
More news about SELVAAG BOLIG.
2. BW LPG (BWLPG.OL)
31.1% sales growth and 20.16% return on equity
BW LPG Limited, an investment holding company, engages in shipowning and chartering activities worldwide. The company operates through Shipping and Product Services segments. It is involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. The company also offers integrated liquified petroleum gas (LPG) delivery services directly to buyers and receivers. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr31.31.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 5.3. Meaning, the purchaser of the share is investing kr5.3 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BW LPG’s EBITDA is 79.74.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 114% and 6%, respectively.
Sales Growth
BW LPG’s sales growth is 20.3% for the current quarter and 31.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 206.6%, now sitting on 2.17B for the twelve trailing months.
More news about BW LPG.
3. NAVAMEDIC (NAVA.OL)
17.8% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.03. Meaning, the purchaser of the share is investing kr32.03 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
Sales Growth
NAVAMEDIC’s sales growth is 17.3% for the present quarter and 17.8% for the next.
Moving Average
NAVAMEDIC’s worth is above its 50-day moving average of kr37.64 and above its 200-day moving average of kr37.61.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.80 at 01:20 EST, way under its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
More news about NAVAMEDIC.
4. DNB BANK (DNB.OL)
12% sales growth and 15.02% return on equity
DNB Bank ASA provides financial services for retail and corporate customers in Norway and internationally. The company offers personal banking products and services, including savings and investment products; loans, such as home mortgages, and car and consumer loans; pet, home and property, travel, and personal insurance products, as well as insurance products for vehicles; retirement savings products; foreign exchange and treasury activities; and Internet and mobile banking services, as well as cards. It also provides business banking products and services comprising savings and investment products consisting of savings accounts, fixed rate deposits, exchange traded products, bonds and commercial papers, asset management, and equity services; financing, such as installment loans, overdraft facility, bank guarantees, leasing, factoring, and trade and export financing services; transaction banking services; research, commodities, bonds and commercial papers, corporate finance, debt capital market, equities, foreign exchange and interest rates, and securities services; and Internet services, including online equity trading, online FX trading, e-confirmation, equities execution, and investor and margin accounts, as well as pension services. In addition, the company provides investment banking services, such as mergers and acquisition, and equity and debt capital market services; foreign exchange, interest rates, equities, commodities, fixed income, research, private equity, and securities services; and corporate banking services. Further, it offers private banking services. The company offers its products and services to various sectors, including energy; financial institutions; healthcare; manufacturing; packaging and forest products; seafood; shipping, offshore, and logistics; and telecom, media, and technology. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, DNB BANK has a trailing twelve months EPS of kr24.8.
PE Ratio
DNB BANK has a trailing twelve months price to earnings ratio of 8.72. Meaning, the purchaser of the share is investing kr8.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.
More news about DNB BANK.
5. BAKKAFROST (BAKKA.OL)
11.7% sales growth and 13.83% return on equity
P/F Bakkafrost, together with its subsidiaries, produces and sells salmon products under the Bakkafrost and Havsbrún brands in North America, Western Europe, Eastern Europe, Asia, and internationally. It operates through four segments: Farming FO; Farming SCT; Value Added Products; and Fishmeal, Oil and Fish Feed. The company is involved in the breeding and on-growing of salmon; harvesting, sale, and distribution of salmon; salmon farming, harvest, filleting, sales, and administration; and production of skinless and boneless portions of salmon. It also produces and sells fishmeal, fish oil, and fish feed. In addition, it engages in production of styrofoam boxes, and biogas and fertilizer; and operates trading of fishes, lumpfish farming business, and freight transportation of goods, as well as produce and sell canned fish products. P/F Bakkafrost was founded in 1968 and is headquartered in Glyvrar, Denmark.
Earnings Per Share
As for profitability, BAKKAFROST has a trailing twelve months EPS of kr11.
PE Ratio
BAKKAFROST has a trailing twelve months price to earnings ratio of 48.09. Meaning, the purchaser of the share is investing kr48.09 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.83%.
More news about BAKKAFROST.
6. SPIE (SPIE.PA)
7.3% sales growth and 8.32% return on equity
SPIE SA provides multi-technical services in the areas of energy and communications. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides technical engineering solutions for buildings; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients; and electrical, mechanical, and HVAC engineering services. The company also offers oil and gas services, including exploring and investigating new fields, buildings and operating facilities, and optimizing production; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the installation and maintenance of electrical systems, heating and air conditioning, building ventilation, utilities and automation for industries; and management of IT and data processing infrastructures. The company was founded in 1900 and is headquartered in Cergy-Pontoise, France.
Earnings Per Share
As for profitability, SPIE has a trailing twelve months EPS of €0.92.
PE Ratio
SPIE has a trailing twelve months price to earnings ratio of 30.15. Meaning, the purchaser of the share is investing €30.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.32%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 8.57B for the twelve trailing months.
Volume
Today’s last reported volume for SPIE is 21347 which is 88.39% below its average volume of 183976.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Sep 20, 2023, the estimated forward annual dividend rate is 0.77 and the estimated forward annual dividend yield is 2.72%.
Yearly Top and Bottom Value
SPIE’s stock is valued at €27.74 at 01:20 EST, below its 52-week high of €29.88 and way higher than its 52-week low of €22.80.
More news about SPIE.
